Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: The logo of Nvidia Corporation is seen during the annual Computex computer exhibition in Taipei JERUSALEM (Reuters) - ...
Add Yahoo as a preferred source to see more of our stories on Google. This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma ...
NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (NYSE:PFE) today announced that its investigational Group B Streptococcus (GBS) vaccine candidate, GBS6 or PF-06760805, received Breakthrough Therapy ...
Learn how pharma company Pfizer makes money through prescription drugs, vaccines, oncology treatments, and global ...
April 29 (Reuters) - The U.S. Food and Drug Administration (FDA) granted full approval for Pfizer's (PFE.N), opens new tab drug for treating cervical cancer patients whose disease had progressed on or ...
As biopharma players continue to parse out what the second Trump administration means for the industry, Pfizer CEO Albert Bourla, Ph.D., outlined one potential response by his company if ...
JERUSALEM (Reuters) - Israel's CytoReason, which uses AI to develop disease models, said on Wednesday it had raised $80 million in a private funding round. Nvidia, Pfizer, Thermo Fisher and venture ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results